LINCOLN, R.I.--(BUSINESS WIRE)--March 7, 2006--MultiCell Technologies, Inc. (OTCBB:MCET), a developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, will host a conference call with a simultaneous webcast tomorrow, Wednesday, March 8, 2006, at 11 a.m. Eastern, to discuss its recent 10-KSB filing and strategic initiatives to develop a broad portfolio of novel medical therapies and stem cell technologies.
